NCT07230470Recruiting
Comparative Study of LoKomat® Exoskeleton VS C-Mill® Treadmill for Gait Recovery in Rehabilitation.
Comparative Study of Working With the LoKomat® Exoskeleton VS C-Mill® Treadmill for Gait Recovery in Rehabilitation and Improvement of Quality of Life in Adult Stroke Patients. Randomised Clinical Trial.
Source: ClinicalTrials.gov · Last updated 4 May 2026
Brief summary (registry, in English)
The use of robotic technology for the treatment of gait in neurological pathologies has provided different results in scientific evidence. In patients with some types of acquired brain damage, such as stroke, the use of Lokomat® therapy can bring improvements in aspects such as gait speed and balance, among other parameters and report greater functional recovery in subacute patients with greater deterioration. Similarly, the use of another technological element such as the C-Mill® reports improvements in various aspects of ambulation and balance in gait treatments for stroke patients. Likewise, the impact on the person's recovery is not only beneficial for gait rehabilitation, but also improves the perception of well-being, which can be positive in the process of readaptation to daily life. The effect of both treatments for gait rehabilitation in adults with stroke and their impact on quality of life in the neurorehabilitation clinic will be studied. adults with stroke and their impact on quality of life at the Lescer neurorehabilitation clinic Lescer, Madrid (Spain). Participants will be assessed at baseline, 4 weeks, 8 weeks and 12 weeks.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 13 Nov 2025
- Start date
- 9 Dec 2025
- Primary completion date
- 25 Feb 2026
- Lead sponsor
- Universidad Pontificia de Salamanca
- Diseases
- Stroke
- NCT number
- NCT07230470
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 9 Dec 2025 to the primary completion date, 25 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Diagnosis of concomitant neurological diseases and craniocerebral trauma. cranioencephalic trauma.
- Other diseases that interfere with the gait process (e.g. disabling arthritis or arthrosis, other neurological diseases, other neurological diseases).
- disabling arthritis or osteoarthritis, other concomitant neurological diseases, etc.).
- \- Contraindications of the robotic tools themselves.
Other illness
- Severe cognitive impairment (Mini-Mental State Examination \< 24.), or impairment that prevents correct understanding of the correct understanding of the messages and explanatory orders of the treatment and its conditions.
Who the study is looking for
- Diagnosis of stroke (haemorrhagic and/or ischaemic) by a specialist physician. .
- Subjects who are cognitively capable and who sign the informed consent form.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidad Pontificia de Salamanca Coordinator of this site? Confirm its status | Salamanca | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.